Credit Suisse Reiterates “Outperform” Rating for Smiths Group (SMIN)
Smiths Group (LON:SMIN)‘s stock had its “outperform” rating restated by Credit Suisse in a research note issued on Monday, ARN reports. They currently have a GBX 1,460 ($23.31) price target on the stock. Credit Suisse’s price objective suggests a potential upside of 4.58% from the stock’s previous close.
A number of other analysts have also recently weighed in on SMIN. Analysts at BNP Paribas reiterated an “outperform” rating on shares of Smiths Group in a research note to investors on Thursday. They now have a GBX 1,525 ($24.35) price target on the stock. Separately, analysts at Bank of America Corp. reiterated an “underperform” rating on shares of Smiths Group in a research note to investors on Thursday. They now have a GBX 1,290 ($20.59) price target on the stock. Finally, analysts at Morgan Stanley reiterated an “equal weight” rating on shares of Smiths Group in a research note to investors on Thursday, October 3rd. Five research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of GBX 1,352.54 ($21.59).
Smiths Group (LON:SMIN) traded up 1.23% on Monday, hitting GBX 1396.00. The stock had a trading volume of 811,816 shares. Smiths Group has a 52 week low of GBX 1018.00 and a 52 week high of GBX 1456.00. The stock’s 50-day moving average is GBX 1329. and its 200-day moving average is GBX 1311.. The company’s market cap is £5.498 billion.
Smiths Group plc is a technology company. It has five divisions: Smiths Detection, Smiths Medical, John Crane, Smiths Interconnect and Flex-Tek.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.